Chabiotech Co.,Ltd.
Develops cell/gene therapies and offers CDMO, biobanking, and genomics services for rare diseases.
085660 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 도산대로 442 청담동 피엔폴루스 3층, 강남구
- Website:
- http://en.chabio.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
CHA Biotech is a global biotechnology company at the forefront of developing innovative cell and gene therapies for rare cancers and incurable diseases. The company leverages its significant expertise in stem cell technology, ranking among the top globally for patent applications in the field. Its core business operations are diversified across several key areas: a world-class Contract Development and Manufacturing Organization (CDMO) specializing in advanced biopharmaceuticals; comprehensive biobanking services, including cord blood (i-Cord) and immune cell storage (Bio Insurance); and precision medicine through its genomics division. Additionally, CHA Biotech develops digital healthcare platforms, offers wellness programs (CHAUM), and provides healthcare consulting. The company's unique strength lies in its vertically integrated model, which spans from R&D and manufacturing to clinical application through an extensive global network of hospitals and medical centers across seven countries.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-18 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (조기난소부전 환자에서의 CordSTEM-ST의 안전성 및 내약성을 평가하기 위한…
|
Korean | 22.9 KB | ||
| 2025-09-08 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 222.3 KB | ||
| 2025-08-25 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 228.6 KB | ||
| 2025-08-13 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 4.7 MB | ||
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 8.5 MB | ||
| 2025-08-04 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.7 KB | ||
| 2025-07-24 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.6 KB | ||
| 2025-07-24 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 229.8 KB | ||
| 2025-07-24 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (알츠하이머병 환자에서 CB-AC-02 치료의 안전성과 잠재적 치료효과를 평가하기…
|
Korean | 15.3 KB | ||
| 2025-07-17 00:00 |
Share Issue/Capital Change
전환주식의전환가액조정 (상환전환우선주)
|
Korean | 13.8 KB | ||
| 2025-07-16 00:00 |
Share Issue/Capital Change
전환가액의조정
|
Korean | 14.1 KB | ||
| 2025-07-16 00:00 |
Share Issue/Capital Change
신주인수권행사가액의조정
|
Korean | 14.3 KB | ||
| 2025-06-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.7 KB | ||
| 2025-06-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.7 KB | ||
| 2025-06-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.7 KB |
Automate Your Workflow. Get a real-time feed of all Chabiotech Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Chabiotech Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
